Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Avacta Group (AVCT) Share News

Avacta In Collaboration Deal With UbiQ To Develop Ubiquitin Reagents

9th May 2014 10:34

LONDON (Alliance News) - Avacta Group PLC Friday said it has signed a collaboration deal with ubiquitylated peptides supplier UbiQ Bio under which the companies will work together to develop reagents that specifically bind to ubiquitin chains. Avacta makes diagnostic tools, consumables and Read More

REPEAT: Avacta Raises GBP10.1M In Placing With Additional Option

7th May 2014 10:18

LONDON (Alliance News) - Avacta Group PLC Wednesday said it has raised GBP10.1 million before expenses through a share placing on 918.2 million shares, which it will use to accelerate the development and commercialisation of Affimers. The shares were placed with both new and existing instit Read More

Avacta Raises GBP10.1M In Share Placing With Additional Option

7th May 2014 10:16

Avacta Loss Narrows, Boosted By Sales Of Analytical Instrument Optim

23rd Apr 2014 12:13

LONDON (Alliance News) - Avacta Group PLC Wednesday posted a narrowed pretax loss for the year to end-January, boosted by increased sales of its analytical instrument Optim. The biotechnology company posted a pretax loss of GBP500,000, narrowed from GBP807,000 in the previous year, as reven Read More

UK Earnings, Trading Statements Calendar - Week Ahead

23rd Apr 2014 05:08

UK Earnings, Trading Statements Calendar - Week Ahead

22nd Apr 2014 15:39

UK Earnings, Trading Statements Calendar - Week Ahead

22nd Apr 2014 05:12

UK Earnings, Trading Statements Calendar - Week Ahead

17th Apr 2014 15:19

UK Earnings, Trading Statements Calendar - Week Ahead

17th Apr 2014 05:16

CORRECT: UK Earnings, Trading Statements Calendar - Week Ahead

16th Apr 2014 16:02

(An item published at 1615 GMT, incorrectly said Taylor Wimpey was issuing a statement April 17. The correct version follows.)<br /><br /><br /> <table border="0" frame="VOID" rules="NONE" cellspacing="0"><colgroup><col width="403" /><col width="256" /></colgroup><tbody><tr><td align="LEFT" Read More

UK Earnings, Trading Statements Calendar - Week Ahead

16th Apr 2014 15:15

Avacta Launches Pancreatitis Test For Dogs

14th Apr 2014 07:06

LONDON (Alliance News) - Avacta Group PLC said Monday it has completed development and validation of a new test for pancreatitis in dogs. The provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare said the new test uses an algorithm to combine the Read More

Avacta Notes Positive Development Progress For Affirmers

20th Mar 2014 12:51

LONDON (Alliance News) - Avacta Group Thursday said it has achieved certain technical milestones towards commercial progress regarding its commercialisation of Affirmer reagents for life sciences research. Affimer reagents are engineered alternatives to antibodies designed to address many o Read More

DIRECTOR DEALINGS: Avacta Non-Executive Exercises 3.5M Share Options

24th Feb 2014 10:43

LONDON (Alliance News) - Avacta Group PLC Monday said Non-Executive Chairman Trevor Nicholls exercised options over 3.5 million shares at an exercise price of 55 pence per share, making the transaction worth GBP1.9 million. Nicholls now holds 3.5 million shares, which represents 0.1% of the Read More

Avacta Collaborating With Liverpool University On Biomarker Research

3rd Feb 2014 11:06

LONDON (Alliance News) - Avacta Group PLC said Monday that it had commenced a collaboration with Liverpool University, working on a project to develop efficient methods of identifying proteins as potential biomarkers. A biomarker is a characteristic that can be measured to indicate a biolog Read More

Avacta Launches New Website To Commercialise Reagents

28th Jan 2014 09:37

LONDON (Alliance News) - Avacta Group PLC said Tuesday that that it had launched a new web site to commercialise its Affimer reagents, which are engineered alternatives to antibodies. The biotechnology company said the new website marks the start of the commercialisation of the Affimers. It Read More

Avacta Group Says First-Half Trading In Line With Market Hopes

24th Jan 2014 08:29

LONDON (Alliance News) - Avacta Group PLC Friday said trading for the first half of its financial year was in line with market expectations, driven by good progress at its analytical unit. In a statement ahead of its annual general meeting, the provider of proprietary diagnostic tools, cons Read More

UK MORNING BRIEFING: Shares Open Higher On Interest Rate Assurance

24th Jan 2014 08:15

LONDON (Alliance News) - UK shares have opened higher Friday, as Bank of England Governor Mark Carney backed off of forward guidance and said there is "no immediate need" to raise interest rates.<br /><br /><strong>Royal Mail</strong> has reported a 2% increase in like-for-like revenues for th Read More

Avacta Group Launches New Canine Lymphoma Blood Test In UK

27th Nov 2013 10:07

Avacta Widens Losses As Revenues Fall On Slow Sales

24th Oct 2013 10:54

FTSE 100 Latest

Value9,201.19

Change23.95